aa 861 has been researched along with Alloxan Diabetes in 1 studies
2,3,5-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone: structure given in first source
docebenone : A member of the class of benzoquinones that is p-benzoquinone in which the hydrogens are substituted by three methyl groups and a 12-hydroxydodeca-5,10-diyn-1-yl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hardy, G | 1 |
| Stanke-Labesque, F | 1 |
| Peoc'h, M | 1 |
| Hakim, A | 1 |
| Devillier, P | 1 |
| Caron, F | 1 |
| Morel, S | 1 |
| Faure, P | 1 |
| Halimi, S | 1 |
| Bessard, G | 1 |
1 other study available for aa 861 and Alloxan Diabetes
| Article | Year |
|---|---|
Cysteinyl leukotrienes modulate angiotensin II constrictor effects on aortas from streptozotocin-induced diabetic rats.
Topics: Angiotensin II; Animals; Aorta; Benzoquinones; Diabetes Mellitus, Experimental; Insulin; Leukotriene | 2001 |